Average Co-Inventor Count = 5.47
ph-index = 14
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merck Frosst Canada, Inc. (22 from 212 patents)
2. Merck Frosst Canada & Co. (5 from 76 patents)
3. Merck + Co., Inc. (1 from 4,770 patents)
28 patents:
1. 6486194 - Use of inhibitors of cyclooxygenase in the treatment of neurodegenerative diseases
2. 6329421 - Diaryl bicyclic heterocycles as inhibitors of cyclooxygenase-2
3. 6225288 - Gamma-ketoacid dipeptides as inhibitors of caspase-3
4. 6222048 - Diaryl-2-(5H)-furanones as Cox-2 inhibitors
5. 6169188 - (Methylsulfonyl)phenyl-2-(5H)-furanones as COX-2 inhibitors
6. 6057319 - 3,4-Diaryl-2-hydroxy-2,5-dihydrofurans as prodrugs to cox-2 inhibitors
7. 6020343 - (Methylsulfonyl)phenyl-2-(5H)-furanones as COX-2 inhibitors
8. 5981576 - (Methylsulfonyl)phenyl-2-(5H)-furanones as COX-2 inhibitors
9. 5925631 - Alkylated styrenes as prodrugs to COX-2 inhibitors
10. 5840746 - Use of inhibitors of cyclooxygenase in the treatment of
11. 5789413 - Alkylated styrenes as prodrugs to COX-2 inhibitors
12. 5710140 - Phenyl heterocycles as COX-2 inhibitors
13. 5698584 - 3,4-diaryl-2-hydroxy-2,5-dihydrofurans as prodrugs to COX-2 inhibitors
14. 5550142 - Phenyl heterocycles as cox-2 inhibitors
15. 5536752 - Phenyl heterocycles as COX-2 inhibitors